Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.54 |
| ▸ | NOS2 | P35228 | 6/20 | 0.48 |
| ▸ | NOS1 | P29475 | 5/20 | 0.48 |
| ▸ | NOS3 | P29474 | 4/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ARG2 | P78540 | 4/20 | 0.48 |
| ▸ | ARG1 | P05089 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.47 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3472931 | 1.00 | GSR (0.54) | GSRNOS2NOS1NOS3CYP2C19 | |
| Hydrochloric Acid SCHEMBL15372840 | 0.98 | GSR (0.52) | GSRNOS2NOS1NOS3CYP2C19 | |
| Hydrochloric Acid SCHEMBL15372842 | 0.98 | GSR (0.52) | GSRNOS2NOS1NOS3CYP2C19 | |
| Hydrochloric Acid SCHEMBL7130280 | 0.98 | GSR (0.52) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL21861898 | 0.87 | GSR (0.54) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL16497780 | 0.84 | GSR (0.56) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL10052913 | 0.84 | GSR (0.56) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL10052915 | 0.84 | GSR (0.56) | GSRNOS2NOS1NOS3CYP2C19 | |
| SCHEMBL19232133 | 0.83 | GSR (0.55) | GSRNOS2NOS1NOS3CYP2C19 | |
| Ammonia Solution, Strong SCHEMBL28728275 | 0.83 | GSR (0.54) | GSRNOS2NOS1NOS3CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11680088-B2 | Bioactive peptides derived from snakes | UNIVERSITEIT LEIDEN (NL) | 2023-06-20 | — | — | US | claimed |
| US-20040054216-A1 | Method for producing lysine derivative | AJINOMOTO CO., INC. (JP) | 2004-03-18 | — | — | US | claimed |
| US-6664412-B2 | Protecting amino group or amino group and carboxyl group of optically active 2-amino-6-methyl-6-nitroheptanoic acid with protecting group, reducing nitro group to synthesize 6,6-dimethyllysine and reacting this with acetic acid | AJINOMOTO CO., INC. (JP) | 2003-12-16 | — | — | US | claimed |
| US-20030105351-A1 | Method for producing lysine derivative | AJINOMOTO CO. INC (JP) | 2003-06-05 | — | — | US | claimed |
| US-20020042537-A1 | Method for producing lysine derivative | AJINOMOTO CO., INC. (JP) | 2002-04-11 | — | — | US | claimed |
| EP-1179599-A2 | Method for producing lysine derivative | Ajinomoto Co., Inc. (JP) | 2002-02-13 | — | — | EP | claimed |
| EP-4681719-A2 | XANTHINE OXIDASE INHIBITOR FORMULATIONS | XORTX Therapeutics Inc. (CA) | 2026-01-21 | — | — | EP | disclosed |
| EP-3915565-B1 | XANTHINE OXIDASE INHIBITOR FORMULATIONS | XORTX THERAPEUTICS INC (CA) | 2025-09-10 | — | — | EP | disclosed |
| EP-4568704-A1 | XANTHINE OXIDASE INHIBITOR FORMULATIONS | XORTX Therapeutics Inc. (CA) | 2025-06-18 | — | — | EP | disclosed |
| US-12037372-B2 | Bioactive peptides derived from snakes | UNIVERSITEIT LEIDEN (NL) | 2024-07-16 | — | — | US | disclosed |
| WO-2024033705-A1 | XANTHINE OXIDASE INHIBITOR FORMULATIONS | XORTX THERAPEUTICS, INC. (CA) | 2024-02-15 | — | — | WO | disclosed |
| US-20230391839-A1 | BIOACTIVE PEPTIDES DERIVED FROM SNAKES | UNIV LEIDEN (NL) | 2023-12-07 | — | — | US | disclosed |
| US-11680088-B2 | Bioactive peptides derived from snakes | UNIVERSITEIT LEIDEN (NL) | 2023-06-20 | — | — | US | disclosed |
| US-20020042537-A1 | Method for producing lysine derivative | AJINOMOTO CO., INC. (JP) | 2002-04-11 | — | — | US | disclosed |
| US-20020042537-A1 | Method for producing lysine derivative | AJINOMOTO CO., INC. (JP) | 2002-04-11 | — | — | US | disclosed |
| EP-1179599-A2 | Method for producing lysine derivative | Ajinomoto Co., Inc. (JP) | 2002-02-13 | — | — | EP | disclosed |
| EP-1179599-A2 | Method for producing lysine derivative | Ajinomoto Co., Inc. (JP) | 2002-02-13 | — | — | EP | disclosed |
| US-20020016366-A1 | 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof | DEGUSSA AG (DE) | 2002-02-07 | — | — | US | disclosed |
| US-20020016366-A1 | 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof | DEGUSSA AG (DE) | 2002-02-07 | — | — | US | disclosed |
| WO-2001083423-A2 | 2,6-DIAMINO-6-METHYL-HEPTANOIC ACID AND DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF | DEGUSSA AG (DE) | 2001-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105351-A1 | Method for producing lysine derivative | JMJD6, SIRT6, KDM6A | GSR 4367/4885NOS2 106/4885NOS1 108/4885 |
| US-20040054216-A1 | Method for producing lysine derivative | JMJD6, SIRT6, KDM6A | GSR 4367/4885NOS2 106/4885NOS1 108/4885 |
| US-20020016366-A1 | 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof | CYP2D6, CYP2B6, CYP2A6 | GSR 4806/4885NOS2 2895/4885NOS1 2390/4885 |
| US-20020042537-A1 | Method for producing lysine derivative | JMJD6, SIRT6, KDM6A | GSR 4367/4885NOS2 106/4885NOS1 108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.